[Clinical strategies and indication expansion of interventional ultrasonography ablative therapy for hepatic tumors] [0.03%]
介入超声消融治疗肝肿瘤的临床策略与适应证拓展
Y G Liang,H Y Wang,Q Y Zhao et al.
Y G Liang et al.
Thermal ablation has become an important treatment option for early-stage hepatocellular carcinoma with the development of interventional ultrasound technology. However, in the treatment of medium-to-large-volume tumors, intrahepatic cholan...
[Application and prospects of artificial intelligence from tool empowerment to paradigm reconstruction for whole-course diagnosis and treatment of liver diseases by ultrasound] [0.03%]
从工具赋能到范式转变：人工智能在超声全病程诊疗肝病中的应用与前景
J Y Huang,Q Q Xu,L D Chen et al.
J Y Huang et al.
The research system and clinical decision-making pathways have been systematically reshaped as the application of artificial intelligence (AI) in the field of ultrasonically has become increasingly mature recently for liver disease imaging....
[Ultrasound technologies' new clinical application for chronic liver diseases] [0.03%]
超声新技术在慢性肝病临床应用进展
M Y Xiao,X Lu,J Y Jin et al.
M Y Xiao et al.
Chronic liver disease and its complications impose a heavy burden，and the limits of liver biopsy tests have rendered non-invasive assessment an urgent clinical need. Multiple novel parameters，such as elasticity，viscosity，fat quantification，and m...
[Ultrasound technology's new application in the diagnosis and treatment of liver cancer] [0.03%]
超声技术在肝癌诊疗中应用的新进展
Q Cai,J Yu
Q Cai
Primary liver cancer (represented by hepatocellular carcinoma and intrahepatic cholangiocarcinoma) is a common clinical malignant liver tumor with a high mortality burden. The disease has high heterogeneity, and diagnosis stratification and...
L T Zhang,J M Hu,J W Wang et al.
L T Zhang et al.
Cellular senescence, a stable state of proliferative arrest induced by stressors such as telomere shortening and DNA damage, is often accompanied by a senescence-associated secretory phenotype (SASP) that is closely related to the imbalance...
[Research progress on the pathogenesis and clinical treatment of cirrhotic cardiomyopathy] [0.03%]
肝硬化心肌病发病机制及临床治疗研究进展
K Y Wang,L Liu
K Y Wang
Liver cirrhosis is often accompanied by cardiovascular lesions, including hyperdynamic circulatory states and myocardial lesions. The hyperdynamic circulatory state manifests as increased cardiac output, peripheral vasodilation, and decreas...
[Pathophysiological mechanisms of coagulation dysfunction associated with liver disease] [0.03%]
肝病相关凝血功能障碍的病理生理机制
H Wang,X Chen,Y Y Lu
H Wang
Coagulation abnormalities associated with liver diseases easily lead to spontaneous and secondary bleeding, which is associated with hemodynamic changes, reduced synthesis of coagulation factors, liver disease-related thrombocytopenia, and ...
[A case of acetaminophen-induced cholestatic liver injury accompanying severe hypercholesterolemia in children] [0.03%]
一例儿童伴严重高胆固醇血症的对乙酰氨基酚致肝细胞损伤病例报告
L Chen,X Y Gao,X Y Liu et al.
L Chen et al.
[Analysis of familial intrahepatic cholestasis caused by ubiquitin-specific peptidase 53 gene mutation] [0.03%]
家族性肝内胆汁淤积症UBIQUTIN特异性肽酶53基因突变分析
H Wang,X Zheng,M M Yu et al.
H Wang et al.
Objective: To investigate the clinical characteristics and gene mutation status of progressive familial intrahepatic cholestasis caused by a ubiquitin-specific peptidase 53 (USP53) gene mutation (USP53-FIC) in a family. Methods: A female in...
[Efficacy and safety profile of magnesium isoglycyrrhizate in patients with a ≤3 fold- elevation of the upper limit of normal transaminases: a multicenter, real-world retrospective study] [0.03%]
甘草酸二铵对血清ALT/AST轻度升高的有效性及安全性：一项多中心回顾性研究
L G Liu,J Yu,Z Z Li et al.
L G Liu et al.
Objective: The clinical efficacy of magnesium isoglycyrrhizinate (MgIG) injection in patients with abnormal transaminase levels ≤3 times the upper limit of normal (ULN) was retrospectively study based on a real-world design. Methods: Data ...